- Home
- PBM vs PRFX Comparison
PBM vs PRFX Comparison
Compare PBM & PRFX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- PBM
- PRFX
- Stock Information
- Founded
- PBM 1994
- PRFX 2007
- Country
- PBM Canada
- PRFX Israel
- Employees
- PBM N/A
- PRFX 6
- Industry
- PBM
- PRFX Biotechnology: Pharmaceutical Preparations
- Sector
- PBM
- PRFX Health Care
- Exchange
- PBM NYSE
- PRFX Nasdaq
- Market Cap
- PBM 3.0M
- PRFX 2.9M
- IPO Year
- PBM N/A
- PRFX 2020
- Fundamental
- Price
- PBM $5.18
- PRFX $1.39
- Analyst Decision
- PBM
- PRFX Hold
- Analyst Count
- PBM 0
- PRFX 1
- Target Price
- PBM N/A
- PRFX N/A
- AVG Volume (30 Days)
- PBM 66.1K
- PRFX 185.0K
- Earning Date
- PBM 07-07-2025
- PRFX 08-14-2025
- Dividend Yield
- PBM N/A
- PRFX N/A
- EPS Growth
- PBM N/A
- PRFX N/A
- EPS
- PBM 5.24
- PRFX N/A
- Revenue
- PBM N/A
- PRFX N/A
- Revenue This Year
- PBM N/A
- PRFX N/A
- Revenue Next Year
- PBM N/A
- PRFX N/A
- P/E Ratio
- PBM $0.94
- PRFX N/A
- Revenue Growth
- PBM N/A
- PRFX N/A
- 52 Week Low
- PBM $2.93
- PRFX $1.25
- 52 Week High
- PBM $701.82
- PRFX $16.63
- Technical
- Relative Strength Index (RSI)
- PBM 53.67
- PRFX 33.95
- Support Level
- PBM $4.52
- PRFX $1.25
- Resistance Level
- PBM $5.23
- PRFX $1.76
- Average True Range (ATR)
- PBM 0.54
- PRFX 0.10
- MACD
- PBM -0.01
- PRFX -0.05
- Stochastic Oscillator
- PBM 49.93
- PRFX 23.53
About PBM PSYENCE BIOMEDICAL LTD
Psyence Biomedical Ltd is a life science biotechnology company pioneering the use of natural psychedelics in mental health and wellbeing. It develops natural psilocybin products for the healing of psychological trauma and its mental health consequences in the context of palliative care. The company has commenced the clinical trial process to evaluate the safety and efficacy of its product candidates. It cultivates natural psilocybin mushrooms at its federally licensed facility in Southern Africa. This product is produced for export to its partners across the world to be processed into a standardized encapsulated product.
About PRFX PainReform Ltd.
PainReform Ltd is a clinical-stage specialty pharmaceutical company. It is focused on the reformulation of established therapeutics. The company's product PRF-110 is based on the local anesthetic ropivacaine, targeting the post-operative pain relief market. PRF-110 is an oil-based, viscous, clear solution that is deposited directly into the surgical wound bed before closure to provide localized and extended post-operative analgesia.